Paper36282174
Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.
Wang L and 9 others. Elife, 2022. Cited by 86 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer. Papers, record 36282174. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36282174
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comprehensive machine-learning survival framework develops a consensus model in large-scale multicenter cohorts for pancreatic cancer.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Profiling | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Artificial Intelligence | |
| Biomarkers | |
| Consensus | |
| Machine Learning | |
| Panobinostat | |
| Practice Guidelines as Topic |
Source PubMed
References78
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34499617 | PRR11 promotes ccRCC tumorigenesis by regulating E2F1 stability. | JCI Insight | 2021 | https://conductscience.org/library/papers/34499617 | PubMed |
| 2 | 33139244 | Tumor Mutational Burden as a Predictive Biomarker in Solid Tumors. | Cancer Discov | 2020 | https://conductscience.org/library/papers/33139244 | PubMed |
| 3 | 23791878 | Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy. | Cancer Lett | 2013 | https://conductscience.org/library/papers/23791878 | PubMed |
| 4 | 35145098 | Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer. | Nat Commun | 2022 | https://conductscience.org/library/papers/35145098 | PubMed |
| 5 | 31570702 | MiR-532-3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/β-catenin signaling. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31570702 | PubMed |
| 6 | 24882743 | Combined newborn screening for familial hemophagocytic lymphohistiocytosis and severe T- and B-cell immunodeficiencies. | J Allergy Clin Immunol | 2014 | https://conductscience.org/library/papers/24882743 | PubMed |
| 7 | 30877282 | The International Cancer Genome Consortium Data Portal. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/30877282 | PubMed |
| 8 | 32467608 | Amplification of transglutaminase 2 enhances tumor-promoting inflammation in gastric cancers. | Exp Mol Med | 2020 | https://conductscience.org/library/papers/32467608 | PubMed |
| 9 | 30967627 | The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells. | Oncogene | 2019 | https://conductscience.org/library/papers/30967627 | PubMed |
| 10 | 31399545 | ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31399545 | PubMed |
| 11 | 34475103 | A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34475103 | PubMed |
| 12 | 33387490 | CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study. | Lancet Oncol | 2021 | https://conductscience.org/library/papers/33387490 | PubMed |
| 13 | 34547082 | Pancreatic Cancer: A Review. | JAMA | 2021 | https://conductscience.org/library/papers/34547082 | PubMed |
| 14 | 26869404 | AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old Puzzle. | JAMA Oncol | 2016 | https://conductscience.org/library/papers/26869404 | PubMed |
| 15 | 33738257 | The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma. | Front Oncol | 2021 | https://conductscience.org/library/papers/33738257 | PubMed |
| 16 | 18657357 | Hypoxia-inducible adrenomedullin accelerates hepatocellular carcinoma cell growth. | Cancer Lett | 2008 | https://conductscience.org/library/papers/18657357 | PubMed |
| 17 | 27488532 | The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma. | Cancer Res | 2016 | https://conductscience.org/library/papers/27488532 | PubMed |
| 18 | 33552157 | Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. | J Oncol | 2021 | https://conductscience.org/library/papers/33552157 | PubMed |
| 19 | 25061874 | EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis. | J Clin Invest | 2014 | https://conductscience.org/library/papers/25061874 | PubMed |
| 20 | 25272957 | Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial. | J Exp Clin Cancer Res | 2014 | https://conductscience.org/library/papers/25272957 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793201 | Integrative Transcriptomics Reveals a Mitochondria-Related Gene Signature in Periodontitis. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793201 | PubMed |
| 42460014 | LTF promotes central nervous system leukemia progression via neutrophil serine proteases. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42460014 | PubMed |
| 42358845 | Clinical Application Progress of Artificial Intelligence in Pancreatic Cancer: From Diagnosis to Immunotherapy. | Oncol Res | 2026 | https://conductscience.org/library/papers/42358845 | PubMed |
| 42164702 | Explainable multi-omics modeling for risk stratification in pancreatic ductal adenocarcinoma. | Gland Surg | 2026 | https://conductscience.org/library/papers/42164702 | PubMed |
| 41855151 | Explainable artificial intelligence for personalized prognosis in pancreatic cancer: A nationwide study from Taiwan. | PLOS Digit Health | 2026 | https://conductscience.org/library/papers/41855151 | PubMed |
| 41629670 | Development and validation of a robust cuproptosis related signature for primary glioma via machine learning aided by loop training and validation. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41629670 | PubMed |
| 41622775 | Single-cell transcriptomics and machine-learning reveal M1 macrophage-driven progression from minimal change disease to focal segmental glomerulosclerosis. | Ren Fail | 2026 | https://conductscience.org/library/papers/41622775 | PubMed |
| 41613752 | DPCDI: an artificial intelligent-derived indicator interpreting the diagnostic, stratification, and therapeutic implications of druggability programmed cell death in heart failure. | Front Genet | 2025 | https://conductscience.org/library/papers/41613752 | PubMed |
| 41559790 | Multilayer metabolomic integration reveals bioenergetic disruption in Long COVID. | J Transl Med | 2026 | https://conductscience.org/library/papers/41559790 | PubMed |
| 41535649 | Integrating single-cell and bulk transcriptomes with machine learning reveals a CAF signature for immunotherapy response in dMMR endometrial cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41535649 | PubMed |
| 41508023 | Single-cell and multi-omics integrative modeling identifies mitochondrial gene HSPE1 as a therapeutic target in osteosarcoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/41508023 | PubMed |
| 41507565 | Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis. | Br J Cancer | 2026 | https://conductscience.org/library/papers/41507565 | PubMed |
| 41415544 | Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation. | Front Oncol | 2025 | https://conductscience.org/library/papers/41415544 | PubMed |
| 41341805 | A Machine Learning-Derived Taurine Metabolism Signature Predicts Prognosis and Immune Landscape in Lung Adenocarcinoma via Integrative Single-Cell Analysis. | Mediators Inflamm | 2025 | https://conductscience.org/library/papers/41341805 | PubMed |
| 41286896 | Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma. | J Transl Med | 2025 | https://conductscience.org/library/papers/41286896 | PubMed |
| 41203941 | Integrative single-cell and bulk RNA-seq analysis identifies glycosyltransferases-related signature in triple negative breast cancer. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/41203941 | PubMed |
| 41164126 | Integrated machine learning-based establishment of a prognostic model in multicenter cohorts for acute myeloid leukemia. | Front Oncol | 2025 | https://conductscience.org/library/papers/41164126 | PubMed |
| 41162783 | Clinical utility of artificial intelligence models in radiology: a systemic scoping review of diagnostic and endovascular applications. | CVIR Endovasc | 2025 | https://conductscience.org/library/papers/41162783 | PubMed |
| 41068840 | Machine learning on transcription factor expression profiles for precision breast cancer therapy. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41068840 | PubMed |
| 41003812 | Multi-omics based consensus subtypes, development of prognostic signature, and identification of INHBB as a potential therapeutic target in colorectal cancer. | Funct Integr Genomics | 2025 | https://conductscience.org/library/papers/41003812 | PubMed |
Genes51
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data8
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36282174
GET https://conductscience.org/api/papers/v1/36282174/references?page=2